Should I buy or sell Organigram stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OGI shares. View OGI analyst ratings or view top-rated stocks .

How have OGI shares performed in 2024?

Organigram's stock was trading at $1.31 at the start of the year. Since then, OGI stock has increased by 39.7% and is now trading at $1.83. View the best growth stocks for 2024 here .

When is Organigram's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024. View our OGI earnings forecast .

How were Organigram's earnings last quarter?

Organigram Holdings Inc. (NASDAQ:OGI) posted its quarterly earnings data on Tuesday, February, 13th. The company reported ($0.14) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.04. The business earned $26.78 million during the quarter, compared to analysts' expectations of $28.61 million. Organigram had a negative trailing twelve-month return on equity of 30.94% and a negative net margin of 173.48%.

When did Organigram's stock split?

Shares of Organigram reverse split before market open on Friday, July 7th 2023. The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What other stocks do shareholders of Organigram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include KushCo (KSHB) , Auxly Cannabis Group (CBWTF) , Supreme Cannabis (SPRWF) , Medical Marijuana (MJNA) , CNBX Pharmaceuticals (CNBX) , MariMed (MRMD) , EVIO (EVIO) and Gran Tierra Energy (GTE) .

How do I buy shares of Organigram?

Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:OGI

Organigram (OGI) Stock Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)

Free OGI Stock Alerts

$1.83

-0.05 (-2.66%)

(As of 04/17/2024 ET)

Compare

Today's Range: $1.78
▼
$1.91
50-Day Range: $1.83
▼
$2.72
52-Week Range: $0.97
▼
$2.91

Volume: 1.43 million shs
Average Volume: 1.38 million shs
Market Capitalization: $188.86 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Organigram alerts:

Organigram MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
5.43% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.64
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.26) to ($0.09) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.31 out of 5 stars

Medical Sector

875th out of 913 stocks

Pharmaceutical Preparations Industry

385th out of 402 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Organigram.

2.0

Short Interest

Percentage of Shares Shorted
5.43% of the float of Organigram has been sold short.
Short Interest Ratio / Days to Cover
Organigram has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Organigram has recently increased by 0.56%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Organigram does not currently pay a dividend.
Dividend Growth
Organigram does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OGI.

3.1

News and Social Media Coverage

News Sentiment
Organigram has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Organigram this week, compared to 1 article on an average week.
Search Interest
14 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 27% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added Organigram to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Organigram insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.09% of the stock of Organigram is held by insiders.
Percentage Held by Institutions
Only 34.63% of the stock of Organigram is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Organigram are expected to grow in the coming year, from ($0.26) to ($0.09) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Organigram is -2.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Organigram is -2.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Organigram has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

Click here to see the details.

About Organigram Stock (NASDAQ:OGI)

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

OGI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OGI Stock News Headlines

April 16, 2024 | americanbankingnews.com

Organigram (NASDAQ:OGI) Upgraded by Alliance Global Partners to "Buy"

April 11, 2024 | markets.businessinsider.com

Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)

April 17, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

April 10, 2024 | stockhouse.com

Organigram Recognized for Executive Gender Diversity by the Globe & Mail's Women Lead Here Report for the Fourth Consecutive Year

April 3, 2024 | finance.yahoo.com

April 3, 2024 | businesswire.com

April 2, 2024 | businesswire.com

Organigram Successfully Closes Previously Announced Underwritten Public Offering

March 27, 2024 | msn.com

Why OrganiGram (OGI) Stock Is Diving

April 17, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

March 27, 2024 | businesswire.com

Organigram Announces Pricing of Overnight Marketed Public Offering

March 26, 2024 | businesswire.com

Organigram Announces Launch of Overnight Marketed Public Offering

March 26, 2024 | businesswire.com

Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment

March 26, 2024 | finance.yahoo.com

OGI Sep 2024 6.000 call

March 26, 2024 | finance.yahoo.com

OGI Jun 2024 4.000 put

March 22, 2024 | businesswire.com

Organigram Receives Health Canada's Final Redetermination on Jolts

March 21, 2024 | investorplace.com

Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5

March 17, 2024 | finance.yahoo.com

OGI Apr 2024 2.000 put

February 28, 2024 | businesswire.com

Organigram Applauds the Standing Committee on Finance's Recommendation on Excise Duty

February 27, 2024 | proactiveinvestors.com

Organigram and Aurora Cannabis increasingly attractive as Canopy Growth's core operations struggle: analysts

February 20, 2024 | investorplace.com

3 Millionaire-Maker Cannabis Penny Stocks to Buy in February 2024

February 13, 2024 | realmoney.thestreet.com

Organigram price target raised by C$0.50 at Alliance Global Partners, here's why

February 13, 2024 | fool.com

Organigram (OGI) Q1 2024 Earnings Call Transcript

February 13, 2024 | msn.com

Organigram Holdings reports Q1 results

February 13, 2024 | finance.yahoo.com

Organigram Reports First Quarter Fiscal 2024 Results

February 7, 2024 | finance.yahoo.com

Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024

January 19, 2024 | finance.yahoo.com

Organigram Announces Appointment of Karina Gehring to Board of Directors

January 18, 2024 | finance.yahoo.com

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT

See More Headlines

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/13/2024
Today: 4/17/2024
Next Earnings (Estimated): 4/23/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:OGI
CUSIP: N/A
CIK: 1620737
Web: www.organigram.ca
Phone: (844) 644-4726
Fax: N/A
Employees: 984
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.80)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-184,340,000.00
Net Margins: -173.48%
Pretax Margin: -156.16%
Return on Equity: -30.94%
Return on Assets: -27.70%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.28
Quick Ratio: 2.11

Sales & Book Value

Annual Sales: $120.01 million
Price / Sales: 1.57
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.48 per share
Price / Book: 0.74

Miscellaneous

Outstanding Shares: 103,200,000
Free Float: 103,111,000
Market Cap: $188.86 million
Optionable: Optionable
Beta: 1.09

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Ms. Beena G. Goldenberg (Age 60)
CEO & Director
Comp: $352.27k
Ms. Helen Martin (Age 46)
Chief Legal Officer & Corporate Secretary
Comp: $223.52k
Mr. Timothy Emberg
Chief Commercial Officer
Mr. Paolo De Luca C.A. (Age 51)
C.F.A, Chief Strategy Officer
Comp: $222.62k
Mr. Greg Guyatt C.A.
CPA, Chief Financial Officer
Ms. Nathalie Batten
Senior Vice President of Operations
Mr. Geoff Riggs
Chief Information Officer
Max Schwartz
Director of Investor Relations
Ms. Megan Amber McCrae
Senior Vice President of Marketing & Communications
Ms. Katrina May McFadden
Chief People Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

OGI Stock Analysis - Frequently Asked Questions

Should I buy or sell Organigram stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OGI shares.
View OGI analyst ratings or view top-rated stocks.
How have OGI shares performed in 2024?: Organigram's stock was trading at $1.31 at the start of the year. Since then, OGI stock has increased by 39.7% and is now trading at $1.83.
View the best growth stocks for 2024 here.
When is Organigram's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.
View our OGI earnings forecast.
How were Organigram's earnings last quarter?: Organigram Holdings Inc. (NASDAQ:OGI) posted its quarterly earnings data on Tuesday, February, 13th. The company reported ($0.14) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.04. The business earned $26.78 million during the quarter, compared to analysts' expectations of $28.61 million. Organigram had a negative trailing twelve-month return on equity of 30.94% and a negative net margin of 173.48%.

When did Organigram's stock split?: Shares of Organigram reverse split before market open on Friday, July 7th 2023. The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.
What other stocks do shareholders of Organigram own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), EVIO (EVIO) and Gran Tierra Energy (GTE).
How do I buy shares of Organigram?: Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OGI) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Organigram (OGI) Stock Price, News & Analysis

Organigram MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Organigram Stock (NASDAQ:OGI)

OGI Stock Price History

OGI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

OGI Stock Analysis - Frequently Asked Questions

Overall MarketRank^™